Related Experiment Video
Updated: Jul 1, 2026

07:08
Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
Published on: January 10, 2019
Reproducibility of optical coherence tomography in multiple sclerosis
Deanna Cettomai1, Mathew Pulicken, Eliza Gordon-Lipkin
1Pathology Bldg, Ste 627, The Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21287, USA.
Archives of Neurology
|September 10, 2008
Summary
Optical coherence tomography (OCT) reliably measures retinal nerve fiber layer (RNFL) thickness in multiple sclerosis (MS) patients and controls. This technique shows high reproducibility across different MS centers, supporting its use in clinical trials.
Area of Science:
- Ophthalmology
- Neurology
- Medical Imaging
Background:
- Optical coherence tomography (OCT) is a key tool for quantifying retinal nerve fiber layer (RNFL) thickness, primarily used in glaucoma monitoring.
- OCT is being evaluated as a crucial outcome measure in multiple sclerosis (MS) clinical trials.
- Reproducibility data for OCT in MS clinical settings were previously lacking.
Purpose of the Study:
- To assess the reproducibility of OCT measurements of mean RNFL thickness.
- To evaluate this reproducibility in both healthy individuals and patients diagnosed with MS.
- To determine the reliability of OCT measurements in undilated eyes.
Main Methods:
- Prospective analysis of 4 healthy controls for interrater, intrarater, and longitudinal reproducibility.
- Cross-sectional analysis involving 396 patients with MS and 153 healthy controls.
- Data collected from multiple sclerosis clinics across 3 academic medical centers.
Main Results:
- Excellent agreement was observed for interrater (ICC, 0.89), intrarater (ICC, 0.98), and intervisit (ICC, 0.91) reproducibility.
- Mean RNFL thickness showed no significant variation among research centers for MS patients (90-93 microm) or healthy controls (103-105 microm).
Conclusions:
- Mean RNFL thickness is reproducibly measurable by trained technicians using the OCT-3 model in MS centers.
- RNFL measurements from MS patients and age-matched controls were consistent across three different research centers.
- OCT demonstrates significant potential as a reliable outcome measure in MS clinical trials.

